FDA warned PurePurge Inc. that its MEDPURE hand sanitizers are unapproved and illegally labeled drugs.
What happened
FDA reviewed PurePurge's website on February 11, 2021 and found it directed consumers to a second site to buy MEDPURE hand sanitizers. FDA said the products are unapproved new drugs and misbranded (illegally labeled) because their claims go beyond allowed topical antiseptic uses, their ingredients do not conform to FDA's over-the-counter antiseptic rules, and the firm was not registered or drug-listed with FDA.
What FDA found
The hand sanitizers are unapproved new drugs because no FDA-approved application is in effect and they are not generally recognized as safe and effective for their labeled uses.
section 505(a) of the FD&C Act, 21 U.S.C. 355(a)The products are misbranded because they do not meet the requirements for nonprescription drugs marketed without an approved application.
section 502(ee) of the FD&C Act, 21 U.S.C. 352(ee)Labeling claims that the products eliminate 99.99% of viruses in 15 seconds and kill viruses, fungi, mold, and spores go beyond the allowed uses for consumer antiseptic hand rubs.
1994 TFM, 59 FR 31402, as amended by 81 FR 42912PurePurge is an active ingredient under FDA's definition based on website claims and label prominence, but hydrogen peroxide and PurePurge are not permitted active ingredients for consumer antiseptic hand rubs.
21 CFR 201.66(b)(2); 1994 TFM, 59 FR 31402PurePurge did not register its facility with FDA as a drug manufacturer.
section 510(i)(1) of the FD&C Act, 21 U.S.C. 360(i)(1); 21 CFR 207.17PurePurge did not list MEDPURE HAND SANITIZERS with FDA.
section 510(j)(1) of the FD&C Act, 21 U.S.C. 360(j)(1); 21 CFR 207.41
What FDA wants
Within 15 working days after receipt, FDA asks PurePurge to notify the office in writing of steps taken to address the violations, explain how recurrence will be prevented, and include related documentation. If corrective action cannot be completed in that time, FDA asks the firm to state the reason and the time needed.
Who should pay attention
- retailers and online marketplaces selling hand sanitizers
- OTC hand sanitizer brands using novel ingredients or antiviral claims
- distributors and importers of consumer antiseptic products
This is a summary. Read the original letter on fda.gov.